• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Carbylan Therapeutics - Articles and news items

Carbylan completes enrollment for its Phase 3 trial of Hydros-TA in osteoarthritis

Industry news / 9 June 2015 / Victoria White

Carbylan Therapeutics has completed enrollment of its COR1.1 Phase 3 pivotal trial of Hydros-TA for the treatment of pain associated with osteoarthritis…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +